{"entity":{"type":"insider","cik":"0001560782","url":"/insider/0001560782","json_url":"/insider/0001560782.json","name":"Daly James M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":47,"n_filings":23,"first":"2014-02-18","last":"2025-11-12","span_basis":"filed_date"},"name_variants":[{"name":"Daly James M","source":"filing","n_filings":23,"first_seen":"2014-02-18","last_seen":"2025-11-12"}],"transactions":[{"id":4331645,"accession":"0001560782-25-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001560782-25-000006","line_url":"/filing/0001560782-25-000006#line-1","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":22.3661,"price_display":"22.37","price_state":"stated","total_value":670983.0,"total_display":"670,983.00","shares_owned_after":4041.0,"shares_owned_after_display":"4,041","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-10","filed_date":"2025-11-12","scope":"insider"},{"id":4728874,"accession":"0001628280-25-009079","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001628280-25-009079","line_url":"/filing/0001628280-25-009079#line-5","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14302.0,"shares_display":"14,302","price_per_share":347.39,"price_display":"347.39","price_state":"stated","total_value":4968371.78,"total_display":"4,968,371.78","shares_owned_after":2682.0,"shares_owned_after_display":"2,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-27","filed_date":"2025-02-28","scope":"insider"},{"id":4728870,"accession":"0001628280-25-009079","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001628280-25-009079","line_url":"/filing/0001628280-25-009079#line-4","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":770.0,"shares_display":"770","price_per_share":348.9433,"price_display":"348.94","price_state":"stated","total_value":268686.341,"total_display":"268,686.34","shares_owned_after":1912.0,"shares_owned_after_display":"1,912","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-27","filed_date":"2025-02-28","scope":"insider"},{"id":4728866,"accession":"0001628280-25-009079","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-25-009079","line_url":"/filing/0001628280-25-009079#line-3","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":398.0,"shares_display":"398","price_per_share":346.9031,"price_display":"346.90","price_state":"stated","total_value":138067.4338,"total_display":"138,067.43","shares_owned_after":16984.0,"shares_owned_after_display":"16,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-27","filed_date":"2025-02-28","scope":"insider"},{"id":3015963,"accession":"0000899243-24-000243","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0000899243-24-000243","line_url":"/filing/0000899243-24-000243#line-19","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6279.0,"shares_display":"6,279","price_per_share":244.1927,"price_display":"244.19","price_state":"stated","total_value":1533285.9633,"total_display":"1,533,285.96","shares_owned_after":4989.0,"shares_owned_after_display":"4,989","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-02","filed_date":"2024-04-03","scope":"insider"},{"id":3015958,"accession":"0000899243-24-000243","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0000899243-24-000243","line_url":"/filing/0000899243-24-000243#line-18","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2991.0,"shares_display":"2,991","price_per_share":244.8946,"price_display":"244.89","price_state":"stated","total_value":732479.7486,"total_display":"732,479.75","shares_owned_after":1998.0,"shares_owned_after_display":"1,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-02","filed_date":"2024-04-03","scope":"insider"},{"id":3015955,"accession":"0000899243-24-000243","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0000899243-24-000243","line_url":"/filing/0000899243-24-000243#line-17","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":842.0,"shares_display":"842","price_per_share":243.2559,"price_display":"243.26","price_state":"stated","total_value":204821.4678,"total_display":"204,821.47","shares_owned_after":11268.0,"shares_owned_after_display":"11,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-02","filed_date":"2024-04-03","scope":"insider"},{"id":3015950,"accession":"0000899243-24-000243","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0000899243-24-000243","line_url":"/filing/0000899243-24-000243#line-16","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":557.0,"shares_display":"557","price_per_share":246.2958,"price_display":"246.30","price_state":"stated","total_value":137186.7606,"total_display":"137,186.76","shares_owned_after":1441.0,"shares_owned_after_display":"1,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-02","filed_date":"2024-04-03","scope":"insider"},{"id":3015946,"accession":"0000899243-24-000243","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0000899243-24-000243","line_url":"/filing/0000899243-24-000243#line-15","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":248.4508,"price_display":"248.45","price_state":"stated","total_value":49690.16,"total_display":"49,690.16","shares_owned_after":1198.0,"shares_owned_after_display":"1,198","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-02","filed_date":"2024-04-03","scope":"insider"},{"id":3015943,"accession":"0000899243-24-000243","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000899243-24-000243","line_url":"/filing/0000899243-24-000243#line-14","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43.0,"shares_display":"43","price_per_share":247.0342,"price_display":"247.03","price_state":"stated","total_value":10622.4706,"total_display":"10,622.47","shares_owned_after":1398.0,"shares_owned_after_display":"1,398","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-02","filed_date":"2024-04-03","scope":"insider"},{"id":3015935,"accession":"0000899243-24-000243","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899243-24-000243","line_url":"/filing/0000899243-24-000243#line-12","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7401.0,"shares_display":"7,401","price_per_share":256.5019,"price_display":"256.50","price_state":"stated","total_value":1898370.5619,"total_display":"1,898,370.56","shares_owned_after":8565.0,"shares_owned_after_display":"8,565","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider"},{"id":3015929,"accession":"0000899243-24-000243","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000899243-24-000243","line_url":"/filing/0000899243-24-000243#line-11","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6809.0,"shares_display":"6,809","price_per_share":255.6366,"price_display":"255.64","price_state":"stated","total_value":1740629.6094,"total_display":"1,740,629.61","shares_owned_after":15966.0,"shares_owned_after_display":"15,966","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider"},{"id":3015925,"accession":"0000899243-24-000243","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000899243-24-000243","line_url":"/filing/0000899243-24-000243#line-10","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3604.0,"shares_display":"3,604","price_per_share":257.2981,"price_display":"257.30","price_state":"stated","total_value":927302.3524,"total_display":"927,302.35","shares_owned_after":4961.0,"shares_owned_after_display":"4,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider"},{"id":3015913,"accession":"0000899243-24-000243","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-24-000243","line_url":"/filing/0000899243-24-000243#line-9","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1460.0,"shares_display":"1,460","price_per_share":258.2834,"price_display":"258.28","price_state":"stated","total_value":377093.764,"total_display":"377,093.76","shares_owned_after":3501.0,"shares_owned_after_display":"3,501","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider"},{"id":3015910,"accession":"0000899243-24-000243","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-24-000243","line_url":"/filing/0000899243-24-000243#line-8","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":262.005,"price_display":"262.00","price_state":"stated","total_value":209604.0,"total_display":"209,604.00","shares_owned_after":2501.0,"shares_owned_after_display":"2,501","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider"},{"id":3015906,"accession":"0000899243-24-000243","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-24-000243","line_url":"/filing/0000899243-24-000243#line-7","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":265.486,"price_display":"265.49","price_state":"stated","total_value":132743.0,"total_display":"132,743.00","shares_owned_after":1472.0,"shares_owned_after_display":"1,472","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider"},{"id":3015900,"accession":"0000899243-24-000243","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-24-000243","line_url":"/filing/0000899243-24-000243#line-6","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":351.0,"shares_display":"351","price_per_share":264.8908,"price_display":"264.89","price_state":"stated","total_value":92976.6708,"total_display":"92,976.67","shares_owned_after":1972.0,"shares_owned_after_display":"1,972","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider"},{"id":3015895,"accession":"0000899243-24-000243","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-24-000243","line_url":"/filing/0000899243-24-000243#line-5","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":274.0,"shares_display":"274","price_per_share":266.9052,"price_display":"266.91","price_state":"stated","total_value":73132.0248,"total_display":"73,132.02","shares_owned_after":1198.0,"shares_owned_after_display":"1,198","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider"},{"id":3015890,"accession":"0000899243-24-000243","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-24-000243","line_url":"/filing/0000899243-24-000243#line-4","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":259.11,"price_display":"259.11","price_state":"stated","total_value":51822.0,"total_display":"51,822.00","shares_owned_after":3301.0,"shares_owned_after_display":"3,301","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider"},{"id":3015883,"accession":"0000899243-24-000243","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-24-000243","line_url":"/filing/0000899243-24-000243#line-3","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":178.0,"shares_display":"178","price_per_share":263.3133,"price_display":"263.31","price_state":"stated","total_value":46869.7674,"total_display":"46,869.77","shares_owned_after":2323.0,"shares_owned_after_display":"2,323","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider"},{"id":8028989,"accession":"0001415889-23-012257","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-012257","line_url":"/filing/0001415889-23-012257#line-2","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":43.741,"price_display":"43.74","price_state":"stated","total_value":437410.0,"total_display":"437,410.00","shares_owned_after":20503.0,"shares_owned_after_display":"20,503","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-14","filed_date":"2023-08-15","scope":"insider"},{"id":8028988,"accession":"0001415889-23-012257","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-012257","line_url":"/filing/0001415889-23-012257#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":43.711,"price_display":"43.71","price_state":"stated","total_value":437110.0,"total_display":"437,110.00","shares_owned_after":30503.0,"shares_owned_after_display":"30,503","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-11","filed_date":"2023-08-15","scope":"insider"},{"id":3054431,"accession":"0001179110-20-011427","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-011427","line_url":"/filing/0001179110-20-011427#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10363.0,"shares_display":"10,363","price_per_share":40.413,"price_display":"40.41","price_state":"stated","total_value":418799.919,"total_display":"418,799.92","shares_owned_after":21002.0,"shares_owned_after_display":"21,002","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-25","filed_date":"2020-11-25","scope":"insider"},{"id":2973657,"accession":"0001179110-20-009018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-009018","line_url":"/filing/0001179110-20-009018#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34337.0,"shares_display":"34,337","price_per_share":29.12,"price_display":"29.12","price_state":"stated","total_value":999893.44,"total_display":"999,893.44","shares_owned_after":31365.0,"shares_owned_after_display":"31,365","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-13","filed_date":"2020-08-13","scope":"insider"},{"id":2831766,"accession":"0001209191-20-028940","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-028940","line_url":"/filing/0001209191-20-028940#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26250.0,"shares_display":"26,250","price_per_share":51.1306,"price_display":"51.13","price_state":"stated","total_value":1342178.25,"total_display":"1,342,178.25","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-11","filed_date":"2020-05-13","scope":"insider"},{"id":7884587,"accession":"0001209191-19-049230","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-049230","line_url":"/filing/0001209191-19-049230#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29600.0,"shares_display":"29,600","price_per_share":37.7873,"price_display":"37.79","price_state":"stated","total_value":1118504.08,"total_display":"1,118,504.08","shares_owned_after":400.0,"shares_owned_after_display":"400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-09","filed_date":"2019-09-11","scope":"insider"},{"id":7884580,"accession":"0001209191-19-049230","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-049230","line_url":"/filing/0001209191-19-049230#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":38.39,"price_display":"38.39","price_state":"stated","total_value":15356.0,"total_display":"15,356.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-09","filed_date":"2019-09-11","scope":"insider"},{"id":8695825,"accession":"0001209191-15-056296","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-056296","line_url":"/filing/0001209191-15-056296#line-6","is_derivative":false,"issuer_cik":"0000879169","issuer_name":"INCYTE CORP","issuer_ticker":"INCY","issuer_name_source":null,"issuer_url":"/issuer/0000879169","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Officer (EVP, Chief Commercial Officer)","officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10710.0,"shares_display":"10,710","price_per_share":108.28,"price_display":"108.28","price_state":"stated","total_value":1159678.8,"total_display":"1,159,678.80","shares_owned_after":3521.0,"shares_owned_after_display":"3,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-23","filed_date":"2015-06-25","scope":"insider"},{"id":8695823,"accession":"0001209191-15-056296","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-056296","line_url":"/filing/0001209191-15-056296#line-5","is_derivative":false,"issuer_cik":"0000879169","issuer_name":"INCYTE CORP","issuer_ticker":"INCY","issuer_name_source":null,"issuer_url":"/issuer/0000879169","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Officer (EVP, Chief Commercial Officer)","officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":981.0,"shares_display":"981","price_per_share":107.84,"price_display":"107.84","price_state":"stated","total_value":105791.04,"total_display":"105,791.04","shares_owned_after":3521.0,"shares_owned_after_display":"3,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-23","filed_date":"2015-06-25","scope":"insider"},{"id":8812241,"accession":"0001209191-15-047528","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-047528","line_url":"/filing/0001209191-15-047528#line-6","is_derivative":false,"issuer_cik":"0000879169","issuer_name":"INCYTE CORP","issuer_ticker":"INCY","issuer_name_source":null,"issuer_url":"/issuer/0000879169","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Officer (EVP, Chief Commercial Officer)","officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11112.0,"shares_display":"11,112","price_per_share":106.43,"price_display":"106.43","price_state":"stated","total_value":1182650.16,"total_display":"1,182,650.16","shares_owned_after":3521.0,"shares_owned_after_display":"3,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-26","filed_date":"2015-05-28","scope":"insider"},{"id":8812240,"accession":"0001209191-15-047528","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-047528","line_url":"/filing/0001209191-15-047528#line-5","is_derivative":false,"issuer_cik":"0000879169","issuer_name":"INCYTE CORP","issuer_ticker":"INCY","issuer_name_source":null,"issuer_url":"/issuer/0000879169","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Officer (EVP, Chief Commercial Officer)","officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":981.0,"shares_display":"981","price_per_share":106.0,"price_display":"106.00","price_state":"stated","total_value":103986.0,"total_display":"103,986.00","shares_owned_after":3521.0,"shares_owned_after_display":"3,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-26","filed_date":"2015-05-28","scope":"insider"},{"id":8901148,"accession":"0001209191-15-036093","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-036093","line_url":"/filing/0001209191-15-036093#line-6","is_derivative":false,"issuer_cik":"0000879169","issuer_name":"INCYTE CORP","issuer_ticker":"INCY","issuer_name_source":null,"issuer_url":"/issuer/0000879169","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Officer (EVP, Chief Commercial Officer)","officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22223.0,"shares_display":"22,223","price_per_share":107.67,"price_display":"107.67","price_state":"stated","total_value":2392750.41,"total_display":"2,392,750.41","shares_owned_after":3521.0,"shares_owned_after_display":"3,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-23","filed_date":"2015-04-24","scope":"insider"},{"id":8901146,"accession":"0001209191-15-036093","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-036093","line_url":"/filing/0001209191-15-036093#line-5","is_derivative":false,"issuer_cik":"0000879169","issuer_name":"INCYTE CORP","issuer_ticker":"INCY","issuer_name_source":null,"issuer_url":"/issuer/0000879169","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Officer (EVP, Chief Commercial Officer)","officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14718.0,"shares_display":"14,718","price_per_share":107.67,"price_display":"107.67","price_state":"stated","total_value":1584687.06,"total_display":"1,584,687.06","shares_owned_after":3521.0,"shares_owned_after_display":"3,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-23","filed_date":"2015-04-24","scope":"insider"},{"id":8792597,"accession":"0001209191-15-018691","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-018691","line_url":"/filing/0001209191-15-018691#line-5","is_derivative":false,"issuer_cik":"0000879169","issuer_name":"INCYTE CORP","issuer_ticker":"INCY","issuer_name_source":null,"issuer_url":"/issuer/0000879169","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Officer (EVP, Chief Commercial Officer)","officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8334.0,"shares_display":"8,334","price_per_share":81.77,"price_display":"81.77","price_state":"stated","total_value":681471.18,"total_display":"681,471.18","shares_owned_after":3521.0,"shares_owned_after_display":"3,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-24","filed_date":"2015-02-25","scope":"insider"},{"id":8792594,"accession":"0001209191-15-018691","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-018691","line_url":"/filing/0001209191-15-018691#line-2","is_derivative":false,"issuer_cik":"0000879169","issuer_name":"INCYTE CORP","issuer_ticker":"INCY","issuer_name_source":null,"issuer_url":"/issuer/0000879169","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Officer (EVP, Chief Commercial Officer)","officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2778.0,"shares_display":"2,778","price_per_share":83.44,"price_display":"83.44","price_state":"stated","total_value":231796.32,"total_display":"231,796.32","shares_owned_after":3521.0,"shares_owned_after_display":"3,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-23","filed_date":"2015-02-25","scope":"insider"},{"id":8824502,"accession":"0001209191-15-006536","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-006536","line_url":"/filing/0001209191-15-006536#line-4","is_derivative":false,"issuer_cik":"0000879169","issuer_name":"INCYTE CORP","issuer_ticker":"INCY","issuer_name_source":null,"issuer_url":"/issuer/0000879169","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Officer (EVP, Chief Commercial Officer)","officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11109.0,"shares_display":"11,109","price_per_share":77.68,"price_display":"77.68","price_state":"stated","total_value":862947.12,"total_display":"862,947.12","shares_owned_after":3521.0,"shares_owned_after_display":"3,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-23","filed_date":"2015-01-26","scope":"insider"},{"id":6258124,"accession":"0001181431-14-039732","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-14-039732","line_url":"/filing/0001181431-14-039732#line-4","is_derivative":false,"issuer_cik":"0000879169","issuer_name":"INCYTE CORP","issuer_ticker":"INCY","issuer_name_source":null,"issuer_url":"/issuer/0000879169","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Officer (EVP, Chief Commercial Officer)","officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11113.0,"shares_display":"11,113","price_per_share":74.43,"price_display":"74.43","price_state":"stated","total_value":827140.59,"total_display":"827,140.59","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-23","filed_date":"2014-12-29","scope":"insider"},{"id":6463313,"accession":"0001181431-14-037404","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-14-037404","line_url":"/filing/0001181431-14-037404#line-4","is_derivative":false,"issuer_cik":"0000879169","issuer_name":"INCYTE CORP","issuer_ticker":"INCY","issuer_name_source":null,"issuer_url":"/issuer/0000879169","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Officer (EVP, Chief Commercial Officer)","officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11111.0,"shares_display":"11,111","price_per_share":74.08,"price_display":"74.08","price_state":"stated","total_value":823102.88,"total_display":"823,102.88","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-24","filed_date":"2014-11-26","scope":"insider"},{"id":6408679,"accession":"0001181431-14-034802","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-14-034802","line_url":"/filing/0001181431-14-034802#line-4","is_derivative":false,"issuer_cik":"0000879169","issuer_name":"INCYTE CORP","issuer_ticker":"INCY","issuer_name_source":null,"issuer_url":"/issuer/0000879169","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Officer (EVP, Chief Commercial Officer)","officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11111.0,"shares_display":"11,111","price_per_share":53.49,"price_display":"53.49","price_state":"stated","total_value":594327.39,"total_display":"594,327.39","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-23","filed_date":"2014-10-24","scope":"insider"},{"id":6610557,"accession":"0001181431-14-032614","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-14-032614","line_url":"/filing/0001181431-14-032614#line-4","is_derivative":false,"issuer_cik":"0000879169","issuer_name":"INCYTE CORP","issuer_ticker":"INCY","issuer_name_source":null,"issuer_url":"/issuer/0000879169","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Officer (EVP, Chief Commercial Officer)","officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11111.0,"shares_display":"11,111","price_per_share":47.65,"price_display":"47.65","price_state":"stated","total_value":529439.15,"total_display":"529,439.15","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-23","filed_date":"2014-09-25","scope":"insider"},{"id":6673672,"accession":"0001181431-14-030292","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-14-030292","line_url":"/filing/0001181431-14-030292#line-4","is_derivative":false,"issuer_cik":"0000879169","issuer_name":"INCYTE CORP","issuer_ticker":"INCY","issuer_name_source":null,"issuer_url":"/issuer/0000879169","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Officer (EVP, Chief Commercial Officer)","officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11111.0,"shares_display":"11,111","price_per_share":51.96,"price_display":"51.96","price_state":"stated","total_value":577327.56,"total_display":"577,327.56","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-25","filed_date":"2014-08-27","scope":"insider"},{"id":6610222,"accession":"0001181431-14-027420","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-14-027420","line_url":"/filing/0001181431-14-027420#line-4","is_derivative":false,"issuer_cik":"0000879169","issuer_name":"INCYTE CORP","issuer_ticker":"INCY","issuer_name_source":null,"issuer_url":"/issuer/0000879169","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Officer (EVP, Chief Commercial Officer)","officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11111.0,"shares_display":"11,111","price_per_share":48.54,"price_display":"48.54","price_state":"stated","total_value":539327.94,"total_display":"539,327.94","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-23","filed_date":"2014-07-25","scope":"insider"},{"id":7051045,"accession":"0001181431-14-024975","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-14-024975","line_url":"/filing/0001181431-14-024975#line-5","is_derivative":false,"issuer_cik":"0000879169","issuer_name":"INCYTE CORP","issuer_ticker":"INCY","issuer_name_source":null,"issuer_url":"/issuer/0000879169","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Officer (EVP, Chief Commercial Officer)","officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8334.0,"shares_display":"8,334","price_per_share":55.92,"price_display":"55.92","price_state":"stated","total_value":466037.28,"total_display":"466,037.28","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-23","filed_date":"2014-06-25","scope":"insider"},{"id":7051044,"accession":"0001181431-14-024975","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-14-024975","line_url":"/filing/0001181431-14-024975#line-4","is_derivative":false,"issuer_cik":"0000879169","issuer_name":"INCYTE CORP","issuer_ticker":"INCY","issuer_name_source":null,"issuer_url":"/issuer/0000879169","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Officer (EVP, Chief Commercial Officer)","officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2777.0,"shares_display":"2,777","price_per_share":56.38,"price_display":"56.38","price_state":"stated","total_value":156567.26,"total_display":"156,567.26","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-23","filed_date":"2014-06-25","scope":"insider"},{"id":6672988,"accession":"0001181431-14-021465","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-14-021465","line_url":"/filing/0001181431-14-021465#line-4","is_derivative":false,"issuer_cik":"0000879169","issuer_name":"INCYTE CORP","issuer_ticker":"INCY","issuer_name_source":null,"issuer_url":"/issuer/0000879169","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Officer (EVP, Chief Commercial Officer)","officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11111.0,"shares_display":"11,111","price_per_share":48.48,"price_display":"48.48","price_state":"stated","total_value":538661.28,"total_display":"538,661.28","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-23","filed_date":"2014-05-28","scope":"insider"},{"id":7031093,"accession":"0001181431-14-016910","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-14-016910","line_url":"/filing/0001181431-14-016910#line-4","is_derivative":false,"issuer_cik":"0000879169","issuer_name":"INCYTE CORP","issuer_ticker":"INCY","issuer_name_source":null,"issuer_url":"/issuer/0000879169","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Officer (EVP, Chief Commercial Officer)","officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30555.0,"shares_display":"30,555","price_per_share":47.71,"price_display":"47.71","price_state":"stated","total_value":1457779.05,"total_display":"1,457,779.05","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-23","filed_date":"2014-04-25","scope":"insider"},{"id":6694958,"accession":"0001181431-14-007428","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-14-007428","line_url":"/filing/0001181431-14-007428#line-4","is_derivative":false,"issuer_cik":"0000879169","issuer_name":"INCYTE CORP","issuer_ticker":"INCY","issuer_name_source":null,"issuer_url":"/issuer/0000879169","owner_cik":"0001560782","owner_name":"Daly James M","owner_url":"/insider/0001560782","role":"Officer (EVP, Chief Commercial Officer)","officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":158331.0,"shares_display":"158,331","price_per_share":66.49,"price_display":"66.49","price_state":"stated","total_value":10527428.19,"total_display":"10,527,428.19","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-13","filed_date":"2014-02-18","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":47,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":47,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":47},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001070494","name":"ACADIA PHARMACEUTICALS INC","url":"/issuer/0001070494","role":"Director","n_filings":3,"first_seen":"2019-09-11","last_seen":"2025-11-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001157601","name":"MADRIGAL PHARMACEUTICALS, INC.","url":"/issuer/0001157601","role":"Director","n_filings":2,"first_seen":"2024-04-03","last_seen":"2025-02-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001159036","name":"HALOZYME THERAPEUTICS, INC.","url":"/issuer/0001159036","role":"Director","n_filings":3,"first_seen":"2020-08-13","last_seen":"2023-08-15"},{"type":"issuer","type_label":"ISSUER","cik":"0000879169","name":"INCYTE CORP","url":"/issuer/0000879169","role":"Officer (EVP, Chief Commercial Officer)","n_filings":15,"first_seen":"2014-02-18","last_seen":"2015-06-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001560782","retrieved_at":"2026-08-21T11:19:59+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}